LifeVantage Completes Successful Human Clinical Trial with New GLP-1 System for Activated Weight Loss* †
SALT LAKE CITY, Sept. 26, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, has completed its randomized, 12-week human …